Hirakawa Hewtech Corp.

2026/11/05 12:54 Updated
Market Cap: $296.6M (¥47.0B)
Stock Price: $20.03 (¥3,175)
Exchange Rate: 1 USD = ¥158.48

Fiscal Year Ending March 2027 Second Quarter (Interim) Financial Summary [Japanese GAAP] (Consolidated)

For the interim period of FY March 2027, consolidated net sales were 25,553.9 million yen (YoY +41.2%), operating income was 2,952.0 million yen (YoY +38.9%), ordinary income was 3,006.0 million yen, and net income attributable to owners of the parent for the interim period was 2,082.0 million yen. The Wire & Processed Products segment performed well; Electronics & Medical Components saw lower sales overall but medical components increased. Full-year forecasts remain unchanged.

Importance:
Page Updated: November 4, 2026
IR Disclosure Date: November 4, 2026

Key Figures

  • Net Sales: 25,553.9 million yen (Year-over-Year +41.2%)
  • Operating Income: 2,952.0 million yen (Year-over-Year +38.9%)
  • Net Income Attributable to Owners of Parent (Interim): 2,082.0 million yen (Year-over-Year +15.4%)

AI要約

Overview of Results

Hirakawa Hewtech Corp.'s consolidated results for the second quarter (interim) of the fiscal year ending March 2027 were: net sales 25,553.9 million yen, operating income 2,952.0 million yen, ordinary income 3,006.0 million yen, and net income attributable to owners of the parent 2,082.0 million yen. Net sales increased significantly year-on-year, driven by strength in the core Wire & Processed Products business. The Electronics & Medical Components segment recorded lower sales overall due to a decline in electronics, but medical components experienced growth. Earnings levels improved steadily on the whole. Supplementary materials and an earnings presentation are scheduled.

Outlook and Segment Trends

By segment, Wire & Processed Products expanded sales supported by contributions from newly mass-produced products and favorable demand in North America. Electronics & Medical Components saw a decline due to the year-on-year reaction from a large OEM project in the prior period, but the medical components field is in a growth phase. The full-year earnings forecast remains as initially published, with exchange rate movements and the progress of new projects potentially affecting results. Financial position remains healthy with total assets of 59,195 million yen and a shareholders' equity ratio of 75.6%.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Hirakawa Hewtech Corp.

Company overview · Stock price · Financial data · All IR

View company page →